BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34531546)

  • 1. Roflupram protects against rotenone-induced neurotoxicity and facilitates α-synuclein degradation in Parkinson's disease models.
    Dong WL; Zhong JH; Chen YQ; Xie JF; Qin YY; Xu JP; Cai NB; Li MF; Liu L; Wang HT
    Acta Pharmacol Sin; 2021 Dec; 42(12):1991-2003. PubMed ID: 34531546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roflupram attenuates α-synuclein-induced cytotoxicity and promotes the mitochondrial translocation of Parkin in SH-SY5Y cells overexpressing A53T mutant α-synuclein.
    Zhong J; Li M; Xu J; Dong W; Qin Y; Qiu S; Li X; Wang H
    Toxicol Appl Pharmacol; 2022 Feb; 436():115859. PubMed ID: 34990728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roflupram, a novel phosphodiesterase 4 inhibitor, inhibits lipopolysaccharide-induced neuroinflammatory responses through activation of the AMPK/Sirt1 pathway.
    Li D; Xu J; Qin Y; Cai N; Cheng Y; Wang H
    Int Immunopharmacol; 2021 Jan; 90():107176. PubMed ID: 33243606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roflumilast escalates α-synuclein aggregate degradation in rotenone-induced Parkinson's disease in rats: Modulation of the ubiquitin-proteasome system and endoplasmic reticulum stress.
    Desouky MA; George MY; Michel HE; Elsherbiny DA
    Chem Biol Interact; 2023 Jul; 379():110491. PubMed ID: 37105514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roflupram exerts neuroprotection via activation of CREB/PGC-1α signalling in experimental models of Parkinson's disease.
    Zhong J; Dong W; Qin Y; Xie J; Xiao J; Xu J; Wang H
    Br J Pharmacol; 2020 May; 177(10):2333-2350. PubMed ID: 31972868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotenone impairs autophagic flux and lysosomal functions in Parkinson's disease.
    Wu F; Xu HD; Guan JJ; Hou YS; Gu JH; Zhen XC; Qin ZH
    Neuroscience; 2015 Jan; 284():900-911. PubMed ID: 25446361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPK-dependent autophagy activation and alpha-Synuclein clearance: a putative mechanism behind alpha-mangostin's neuroprotection in a rotenone-induced mouse model of Parkinson's disease.
    Parekh P; Sharma N; Sharma M; Gadepalli A; Sayyed AA; Chatterjee S; Kate A; Khairnar A
    Metab Brain Dis; 2022 Dec; 37(8):2853-2870. PubMed ID: 36178640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of indole-3-carbinol on the rotenone rat model of Parkinson's disease: Impact of the SIRT1-AMPK signaling pathway.
    Mohamad KA; El-Naga RN; Wahdan SA
    Toxicol Appl Pharmacol; 2022 Jan; 435():115853. PubMed ID: 34973289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.
    Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY
    Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models.
    Prieto Huarcaya S; Drobny A; Marques ARA; Di Spiezio A; Dobert JP; Balta D; Werner C; Rizo T; Gallwitz L; Bub S; Stojkovska I; Belur NR; Fogh J; Mazzulli JR; Xiang W; Fulzele A; Dejung M; Sauer M; Winner B; Rose-John S; Arnold P; Saftig P; Zunke F
    Autophagy; 2022 May; 18(5):1127-1151. PubMed ID: 35287553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma exosomes impair microglial degradation of α-synuclein through V-ATPase subunit V1G1.
    Li Y; Wang Y; Kou L; Yin S; Chi X; Sun Y; Wu J; Jin Z; Zhou Q; Zou W; Wang T; Xia Y
    CNS Neurosci Ther; 2024 May; 30(5):e14738. PubMed ID: 38702933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural-Induced Human Adipose Tissue-Derived Stem Cells Conditioned Medium Ameliorates Rotenone-Induced Toxicity in SH-SY5Y Cells.
    Ramalingam M; Jang S; Jeong HS
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Involvement of Progranulin for α-Synuclein Reduction through Autolysosome Formation.
    Fujimori H; Ohba T; Nakamura S; Shimazawa M; Hara H
    Biol Pharm Bull; 2023; 46(8):1032-1040. PubMed ID: 37532554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
    Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
    Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roflupram, a Phosphodiesterase 4 Inhibitior, Suppresses Inflammasome Activation through Autophagy in Microglial Cells.
    You T; Cheng Y; Zhong J; Bi B; Zeng B; Zheng W; Wang H; Xu J
    ACS Chem Neurosci; 2017 Nov; 8(11):2381-2392. PubMed ID: 28605578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy-dependent removal of α-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson's disease.
    Guo YL; Duan WJ; Lu DH; Ma XH; Li XX; Li Z; Bi W; Kurihara H; Liu HZ; Li YF; He RR
    Acta Pharmacol Sin; 2021 Apr; 42(4):518-528. PubMed ID: 32724177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Oleracein E, a Neuroprotective Tetrahydroisoquinoline, on Rotenone-Induced Parkinson's Disease Cell and Animal Models.
    Sun H; He X; Liu C; Li L; Zhou R; Jin T; Yue S; Feng D; Gong J; Sun J; Ji J; Xiang L
    ACS Chem Neurosci; 2017 Jan; 8(1):155-164. PubMed ID: 27731637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of apigenin on rotenone induced rat model of Parkinson's disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis.
    Anusha C; Sumathi T; Joseph LD
    Chem Biol Interact; 2017 May; 269():67-79. PubMed ID: 28389404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-asarone protects against MPTP-induced Parkinson's disease via regulating long non-coding RNA MALAT1 and inhibiting α-synuclein protein expression.
    Zhang QS; Wang ZH; Zhang JL; Duan YL; Li GF; Zheng DL
    Biomed Pharmacother; 2016 Oct; 83():153-159. PubMed ID: 27470562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective Effect of Phloretin in Rotenone-Induced Mice Model of Parkinson's Disease: Modulating mTOR-NRF2-p62 Mediated Autophagy-Oxidative Stress Crosstalk.
    Shirgadwar SM; Kumar R; Preeti K; Khatri DK; Singh SB
    J Alzheimers Dis; 2023; 94(s1):S109-S124. PubMed ID: 36463449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.